CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study

So-Yeon Jeon, Hye Sook Han, Woo Kyun Bae, Moo-Rim Park, Hyeok Shim, Sang-Cheol Lee, Se-Il Go, Hwan Jung Yun, Yong-Jin Im, Eun-Kee Song

Cancer Research and Treatment. 2019;51(1):90-97. Published online 2018 February 27 DOI: https://doi.org/10.4143/crt.2017.577

So-Yeon Jeon, Hye Sook Han, Woo Kyun Bae, Moo-Rim Park, Hyeok Shim, Sang-Cheol Lee, Se-Il Go, Hwan Jung Yun, Yong-Jin Im, Eun-Kee Song

Cancer Research and Treatment. 2019;51(1):90-97

Link1

Link2 Link3

A randomized, double blind, placebo-controlled study evaluating efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide

W. Nipondhkit

Annals of Oncology. 2018;29:ix131

Link1 Link2 Link3

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study

Naomi Mizukami, Masanori Yamauchi, Kazuhiko Koike, Akihiko Watanabe, Koji Ichihara, Naoya Masumori, Michiaki Yamakage

Journal of Pain and Symptom Management. 2014;47(3):542-550

Link1 Link2

J-FORCE study: A randomized, double-blind, placebo-controlled phase III study evaluating olanzapine (5 mg) combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based, highly emetogenic chemotherapy

H. Hashimoto, S. Iwasa, M. Abe, T. Yanai, S. Zenda, T. Yamaguchi, H. Kaba, H. Fukuda, H. Terakado, Y. Ohe

Annals of Oncology. 2017;28:v564-v565

Link1 Link2 Link3

Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens

Sachin Hingmire, Nirmal Raut

South Asian Journal of Cancer. 2015;04(01):007-010

Link1

Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting with a Moderately Emetogenic Chemotherapy: a Multicenter, Placebo-Controlled, Double-Blind, Randomized Study in Japanese Gynecologic Patients Receiving Paclitaxel and Carboplatin

H. Yahata, K. Sonoda, H. Kobayashi, M. Shimokawa, T. Ohgami, T. Saito, S. Ogawa, K. Sakai, A. Ichinoe, Y. Ueoka, Y. Hasuo, M. Nishida, R. Oishi, K. Kato

Annals of Oncology. 2014;25:iv518

Link1 Link2 Link3

Study protocol for J-SUPPORT 1604 (J-FORCE): a randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy

Hironobu Hashimoto, Masakazu Abe, Takako Yanai, Takuhiro Yamaguchi, Sadamoto Zenda, Yosuke Uchitomi, Haruhiko Fukuda, Mikio Mori, Satoru Iwasa, Noboru Yamamoto, Yuichiro Ohe

Japanese Journal of Clinical Oncology. 2018;48(10):950-952

Link1

Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin

Hideaki Yahata, Hiroaki Kobayashi, Kenzo Sonoda, Mototsugu Shimokawa, Tatsuhiro Ohgami, Toshiaki Saito, Shinji Ogawa, Kunihiro Sakai, Akimasa Ichinoe, Yousuke Ueoka, Yasuyuki Hasuo, Makoto Nishida, Satohiro Masuda, Kiyoko Kato

International Journal of Clinical Oncology. 2015;21(3):491-497

Link1

Link2 Link3

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Annals of Oncology. 2014;25(1):300

Link1 Link2 Link3

Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study

Gábor Kovács, Antonio E Wachtel, Elena V Basharova, Tulla Spinelli, Pierre Nicolas, Edita Kabickova

The Lancet Oncology. 2016;17(3):332-344

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.